Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973518 · ClinicalTrials.gov registry record
Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
A clinical trial, sponsored by Orasi Medical.
- Completed
- Registry status
- 160
- Enrollment target
NCT00973518: Completed study, sponsored by Orasi Medical.
NCT00973518 is a clinical trial that has completed, run by Orasi Medical. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00973518 has completed, sponsored by Orasi Medical.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The current study is intended to enrich and extend the database of Alzheimer's Disease (AD) and healthy control (HC) MEG scans and will include patients meeting DSM-IV-TR criteria for dementia of Alzheimer's type, and age- and gender-matched HC subjects meeting criteria of normal neurological function. This study will include 2 MEG and electroencephalography (EEG) scans on approximately 80 AD subjects and 80 HC subjects over approximately 30 days. All subjects will have MEG/EEG scans at baseline and 28 - 35 days after baseline. Within one day of each scan visit AD subjects will undergo 4 standard functional tests while HC subjects will undergo 2 standard functional tests. This study will test the following hypotheses: * MEG scans of resting-state, eyes-open brain function reveal patterns of correlated activity that differ between HC subjects and subjects diagnosed with dementia of Alzheimer's type; * Patterns of correlated activity measured in AD subjects correspond to other measures of disease severity such as standard functional test scores; * MEG scan patterns for HC subjects are consistent across repeated measures taken over a 30 day period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00973518
The ClinicalTrials.gov registry entry for NCT00973518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orasi Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00973518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00973518 about?
NCT00973518 is a clinical study titled "Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)". The current study is intended to enrich and extend the database of Alzheimer's Disease (AD) and healthy control (HC) MEG scans and will include patients meeting DSM-IV-TR criteria for dementia of Alzheimer's type, and age- and gender-matched HC subjects meeting criteria of normal neurological functi...
What is the current status of trial NCT00973518?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2009-09. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00973518?
This trial is sponsored by Orasi Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.